PLSE Pulse Biosciences Inc

Pulse Biosciences Inc is a development stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES for biomedical applications.

$18.47  +0.29 (1.60%)
As of 06/24/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  05/18/2016
Outstanding shares:  26,460,353
Average volume:  41,955
Market cap:   $481,049,218
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    74587B101
ISIN:        US74587B1017
Sedol:      BD02SG8
Valuation   (See tab for details)
PE ratio:   -35.54
PB ratio:   23.89
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy